Drug Shortage Report for ORAP
| Report ID | 2024 |
| Drug Identification Number | 00313815 |
| Brand name | ORAP |
| Common or Proper name | ORAP |
| Company Name | AA PHARMA INC |
| Market Status | DORMANT |
| Active Ingredient(s) | PIMOZIDE |
| Strength(s) | 2 MG |
| Dosage form(s) | Tablet |
| Route of administration | Oral |
| Packaging size | 100 Bottle |
| ATC code | N05AG |
| ATC description | ANTIPSYCHOTICS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2015-04-15 |
| Estimated end date | Unknown |
| Actual end date | 2017-07-28 |
| Shortage status | Resolved |
| Updated date | 2020-08-06 |
| Company comments | product discontinued |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2020-08-06 | French | Compare |
| v3 | 2020-08-06 | English | Compare |
| v2 | 2017-03-13 | French | Compare |
| v1 | 2017-03-13 | English | Compare |
Showing 1 to 4 of 4